Literature DB >> 16301345

Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region.

.   

Abstract

BACKGROUND: Although interest in multifactorial interventions for cardiovascular disease is increasing, data on the strength and shape of the joint effects of blood pressure and cholesterol levels on the risk of cardiovascular disease are scarce, confined primarily to coronary heart disease (CHD) mortality in early middle-aged Western populations. METHODS AND
RESULTS: This analysis included 29 cohorts from Asia (78% of the total 380,216 participants) and 7 from Australia and New Zealand, with a total of 2,547,447 person-years of observation. Stratified time-dependent Cox proportional-hazards analyses were used to regress time until first event against baseline systolic blood pressure (SBP) and total cholesterol levels. A total of 3079 CHD and 4247 stroke events occurred; stroke subtypes were confirmed by CT, MRI, or necropsy in 1471 (35%) stroke events. Usual values of SBP were strongly linearly associated with ischemic stroke, hemorrhagic stroke, and CHD. The slope of the association with SBP became steeper with decreasing levels of cholesterol for ischemic stroke (P=0.007) and CHD (P< or =0.0001). For example, for the cholesterol groups of <4.75, 4.75 to 5.49, 5.50 to 6.24, and > or =6.25 mmol/L, each 10-mm Hg-higher systolic pressure was associated with 34% (95% CI, 30% to 37%), 28% (95% CI, 21% to 35%), 25% (95% CI, 18% to 32%), and 21% (95% CI, 13% to 27%) higher CHD risk, respectively. Adjustments for other leading cardiovascular risk factors made no appreciable differences in these results.
CONCLUSIONS: In Asia-Pacific populations, there are hazards of increasing SBP at all cholesterol levels and hazards of increasing cholesterol at all levels of SBP, but the associations of SBP with CHD risk and ischemic stroke risk are slightly steeper among those with low cholesterol levels. The joint effects of SBP and total cholesterol on cardiovascular disease seem consistent across various Western and Asian populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301345     DOI: 10.1161/CIRCULATIONAHA.105.537472

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Blood pressure, cholesterol and cardiovascular disease in Thailand.

Authors:  Panrasri Khonputsa; J Lennert Veerman; Prin Vathesatogkit; Somlax Vanavanan; Stephen Lim; Melanie Bertram; Theo Vos; Wipa Ratanachaiwong; Sukit Yamwong
Journal:  Heart Asia       Date:  2010-07-11

2.  Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita study.

Authors:  Rumi Tsukinoki; Tomonori Okamura; Makoto Watanabe; Yoshihiro Kokubo; Aya Higashiyama; Kunihiro Nishimura; Misa Takegami; Yoshitaka Murakami; Akira Okayama; Yoshihiro Miyamoto
Journal:  Am J Hypertens       Date:  2014-04-08       Impact factor: 2.689

3.  Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.

Authors:  Valentina Perrone; Chiara Veronesi; Marco Gambera; Giulio Nati; Francesco Perone; Paola Fausta Tagliabue; Luca Degli Esposti; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-08-28

4.  Blood pressure, fitness, and lipid profiles of rural women in the wellness for women project.

Authors:  Patricia A Hageman; Carol H Pullen; Susan Noble Walker; Linda S Boeckner
Journal:  Cardiopulm Phys Ther J       Date:  2010-09

5.  Combined Association of Low-Density Lipoprotein Cholesterol Levels and Systolic Blood Pressure to the Outcome of Intracerebral Hemorrhage: Data from the China Stroke Center Alliance.

Authors:  Yarong Ding; Yu Wang; Liping Liu; Hongqiu Gu; Kaixuan Yang; Zixiao Li; Xingquan Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-06-18       Impact factor: 7.310

Review 6.  Epidemiology of atherosclerosis in systemic lupus erythematosus.

Authors:  Mandana Nikpour; Murray B Urowitz; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

7.  An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.

Authors:  Anthony Rodgers; Anushka Patel; Otavio Berwanger; Michiel Bots; Richard Grimm; Diederick E Grobbee; Rod Jackson; Bruce Neal; Jim Neaton; Neil Poulter; Natasha Rafter; P Krishnam Raju; Srinath Reddy; Simon Thom; Stephen Vander Hoorn; Ruth Webster
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

8.  Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam.

Authors:  Quang Ngoc Nguyen; Son Thai Pham; Loi Doan Do; Viet Lan Nguyen; Stig Wall; Lars Weinehall; Ruth Bonita; Peter Byass
Journal:  Int J Hypertens       Date:  2012-03-04       Impact factor: 2.420

9.  Implementation of guidelines for the management of arterial hypertension. The impulsion study.

Authors:  Asterios Karagiannis; Apostolos I Hatzitolios; Vasilios G Athyros; Kalliopi Deligianni; Charalambos Charalambous; Christos Papathanakis; Georgios Theodosiou; Theodoros Drakidis; Veronika Chatzikaloudi; Chysanthi Kamilali; Sotirios Matsiras; Athanasios Matziris; Christos Savopoulos; Maria Baltatzi; Jobst Rudolf; Konstantinos Tziomalos; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-05-05

10.  Stroke and nutrition: a review of studies.

Authors:  Mehdi Foroughi; Mohsen Akhavanzanjani; Zahra Maghsoudi; Reza Ghiasvand; Fariborz Khorvash; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.